Forte TM - Search Results

1

A phospholipid-apolipoprotein A-I nanoparticle containing amphotericin B as a drug delivery platform with cell membrane protective properties.

Burgess BL, Cavigiolio G, Fannucchi MV, Illek B, Forte TM, Oda MN. Burgess BL, et al. Among authors: forte tm. Int J Pharm. 2010 Oct 31;399(1-2):148-55. doi: 10.1016/j.ijpharm.2010.07.057. Epub 2010 Aug 7. Int J Pharm. 2010. PMID: 20696226 Free PMC article.

2

NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency.

Burgess BL, He Y, Baker MM, Luo B, Carroll SF, Forte TM, Oda MN. Burgess BL, et al. Among authors: forte tm. Int J Nanomedicine. 2013;8:4733-43. doi: 10.2147/IJN.S50113. Epub 2013 Dec 12. Int J Nanomedicine. 2013. PMID: 24379661 Free PMC article.

3

Optimized bacterial expression of human apolipoprotein A-I.

Ryan RO, Forte TM, Oda MN. Ryan RO, et al. Among authors: forte tm. Protein Expr Purif. 2003 Jan;27(1):98-103. doi: 10.1016/s1046-5928(02)00568-5. Protein Expr Purif. 2003. PMID: 12509990

4

The C-terminal domain of apolipoprotein A-I contains a lipid-sensitive conformational trigger.

Oda MN, Forte TM, Ryan RO, Voss JC. Oda MN, et al. Among authors: forte tm. Nat Struct Biol. 2003 Jun;10(6):455-60. doi: 10.1038/nsb931. Nat Struct Biol. 2003. PMID: 12754494

5

Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.

Shu X, Nelbach L, Weinstein MM, Burgess BL, Beckstead JA, Young SG, Ryan RO, Forte TM. Shu X, et al. Among authors: forte tm. Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2504-9. doi: 10.1161/ATVBAHA.110.210815. Epub 2010 Oct 21. Arterioscler Thromb Vasc Biol. 2010. PMID: 20966404 Free PMC article.

6

Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis.

Beckstead JA, Oda MN, Martin DD, Forte TM, Bielicki JK, Berger T, Luty R, Kay CM, Ryan RO. Beckstead JA, et al. Among authors: forte tm. Biochemistry. 2003 Aug 12;42(31):9416-23. doi: 10.1021/bi034509t. Biochemistry. 2003. PMID: 12899628 Free article.

7

Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity.

Oda MN, Bielicki JK, Berger T, Forte TM. Oda MN, et al. Among authors: forte tm. Biochemistry. 2001 Feb 13;40(6):1710-8. doi: 10.1021/bi001922h. Biochemistry. 2001. PMID: 11327831

8

Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.

Nikanjam M, Blakely EA, Bjornstad KA, Shu X, Budinger TF, Forte TM. Nikanjam M, et al. Among authors: forte tm. Int J Pharm. 2007 Jan 2;328(1):86-94. doi: 10.1016/j.ijpharm.2006.07.046. Epub 2006 Jul 31. Int J Pharm. 2007. PMID: 16959446 Free article.

9

Baculovirus-mediated expression and purification of human serum paraoxonase 1A.

Brushia RJ, Forte TM, Oda MN, La Du BN, Bielicki JK. Brushia RJ, et al. Among authors: forte tm. J Lipid Res. 2001 Jun;42(6):951-8. J Lipid Res. 2001. PMID: 11369803 Free article.

10

Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration.

Forte TM, Oda MN, Knoff L, Frei B, Suh J, Harmony JA, Stuart WD, Rubin EM, Ng DS. Forte TM, et al. J Lipid Res. 1999 Jul;40(7):1276-83. J Lipid Res. 1999. PMID: 10393212 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters